SLITRK5 is a cellular protein whose normal function appears to suppress bone formation and could be a potential new target for the treatment ofosteoporosis, according to a collaborative study conducted by Weill Cornell Medicine and NewYork-Presbyterian researchers.
Cells manifesting the SLITRK5 protein are marked with magenta (left) and a bone-forming osteoblast marker in green (center). These markers were observed in the cancellous bone in the medulla space (top) or on the outer layer covering the bone (bottom). The overlap between these two markers (right) shows that SLITRK5 is found in bone-forming osteoblasts but not in other cell types, helping to make SLITRK5 a target for skeletal disease treatment. Credit: Dr. Matthew Greenblatt and Dr. Jun Sun
There Research was published in the scientific journal Nature Communications.
Read Also
- Neuilly-sur-Marne: A three-year-old child falls into a hole nearly 3 m, his parents attack the town hall Nov 21, 2022
- Huawei P30 Pro : toward a model of “New Edition” ? May 6, 2020
- The hidden trick in the Google search engine to “see” a ghost or a skeleton in your home Oct 30, 2020
- Coupe de France: The Hyères club of Mourad Boudjellal announces that it will file a complaint against that of Saint-Estève Nov 24, 2022
- WWDC 2022: minute by minute of Apple’s special event Jun 6, 2022
- Mohammed bin Rashid orders the release of 520 inmates on the occasion of Eid Al-Adha Jul 14, 2021
- MotoGP / Ciabatti praises loyal Miller | FormulaPassion.it Sep 19, 2021